This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Festa, A. Articles by Schernthaner, G. Search for Related Content PubMed PubMed Citation Articles by Festa, A. Articles by Schernthaner, G.

Trp⁶⁴Arg Polymorphism of the ß₃-Adrenergic Receptor Gene in Pregnancy: Association with Mild Gestational Diabetes Mellitus

Department of Medicine, Division of Clinical Epidemiology, University of Texas Health Science Center (A.F., S.H.), San Antonio, Texas 78284; and the Department of Medicine 1 (A.F., N.S., G.S.) and the Institute of Clinical Chemistry (W.K., P.H.), Rudolfstiftung Hospital, Vienna, Austria

Address all correspondence and requests for reprints to: Andreas Festa, M.D., Department of Medicine, Division of Clinical Epidemiology, University of Texas Health Science Center, 7703 Floyd Curl Drive, San Antonio, Texas 78284-7873. E-mail: festa{at}uthscsa.edu

A missense mutation of the ß₃-adrenergic receptor gene (Trp⁶⁴Arg) has been associated with obesity and increased capacity to gain weight in nonpregnant populations. Furthermore, the mutation is a potential modifying factor in the etiology of impaired glucose tolerance and type 2 diabetes. We studied the relation of the ß₃-adrenergic receptor genotype to glucose tolerance during pregnancy, a state of physiological insulin resistance. In 179 pregnant women (mean age, 28.5 ± 0.4 yr), a 2-h oral glucose tolerance test was performed between gestational weeks 20 and 31. The ß₃-adrenergic receptor genotype was assessed using restriction fragment length polymorphism.

The frequency of the Arg⁶⁴ allele was 9.15%. In women with mild gestational diabetes (n = 70), as defined by 60 min postload glucose values, the Trp⁶⁴Arg genotype was more frequent than in women with normal glucose tolerance (n = 109; 26% vs. 11%; P = 0.01). Furthermore, the Trp⁶⁴Arg polymorphism was associated with increased weight gain during pregnancy (baseline to gestational weeks 20–31) and increased postload glucose, insulin, and C peptide values during the oral glucose tolerance test.

The results of the present study extend current knowledge about the association of the Trp⁶⁴Arg ß₃-adrenergic receptor polymorphism with glucose tolerance to a pregnant population. The association with mild gestational diabetes suggests that the impact of the polymorphism may be clinically important during pregnancy, a state of physiological insulin resistance.

This article has been cited by other articles:

				R. P. Erickson and P. E. Graves Genetic Variation in {beta}-Adrenergic Receptors and Their Relationship to Susceptibility for Asthma and Therapeutic Response Drug Metab. Dispos., April 1, 2001; 29(4): 557 - 561. [Abstract] [Full Text]